Terragen Holdings Ltd AI Stock Analysis
Want to see AU:TGH full AI Analyst Report?
Terragen Holdings Ltd (TGH) AI Stock Analysis
Terragen Holdings Ltd
(ASX:TGH)
The overall score is very low, driven primarily by severe operational and cash flow distress. The company is deeply unprofitable with collapsing margins and negative cash flow, which is a critical risk to its viability. The balance sheet provides the only meaningful support, but it is being rapidly eroded by ongoing losses. Technicals confirm extreme weakness with the stock in a sustained downtrend and deeply oversold.
Terragen Holdings Ltd (TGH) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 7.04M
- Dividend Yield
- ―
- Average Volume (3M)
- 131.16K
- Price to Earnings (P/E)
- -2.4
- Beta (1Y)
- 0.16
- Revenue Growth
- -11.34%
- EPS Growth
- 30.34%
- Country
- Australia
- Employees
- 15
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Agricultural Inputs
Terragen Holdings Ltd Business Overview & Revenue Model
Company Description
Based in Coolum Beach, Australia, and founded in 1996, Terragen Holdings Limited specializes in the innovation, production, and commercialization of biological products for the agricultural sector. The company distributes its solutions throughout Aus...
Terragen Holdings Ltd Financial Statement Overview
Summary
Financial performance is critically weak. The income statement shows collapsing margins and persistent net losses, and cash flow is deeply negative with the company burning through cash. The only support comes from a strong balance sheet with very low debt and a recently strengthened equity base, which provides a temporary buffer against operational distress.
Income Statement
18Very NegativeBalance Sheet
72PositiveCash Flow
15Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.43M | 1.43M | 1.62M | 2.14M | 3.28M | 2.89M |
| Gross Profit | 524.91K | 524.91K | 792.23K | 2.06M | 3.21M | 2.62M |
| EBITDA | -4.09M | -4.09M | -4.53M | -3.50M | -3.46M | -5.67M |
| Net Income | -3.75M | -3.75M | -3.72M | -3.01M | -3.23M | -5.41M |
Balance Sheet | ||||||
| Total Assets | 10.59M | 10.59M | 8.12M | 6.95M | 6.35M | 9.22M |
| Cash, Cash Equivalents and Short-Term Investments | 7.36M | 7.36M | 4.81M | 4.54M | 4.17M | 6.67M |
| Total Debt | 275.57K | 275.57K | 735.45K | 542.23K | 239.37K | 332.26K |
| Total Liabilities | 1.09M | 1.09M | 1.55M | 1.63M | 1.27M | 1.46M |
| Stockholders Equity | 9.50M | 9.50M | 6.57M | 5.32M | 5.08M | 7.76M |
Cash Flow | ||||||
| Free Cash Flow | -3.49M | -3.49M | -3.03M | -2.35M | -2.91M | -4.97M |
| Operating Cash Flow | -3.38M | -3.38M | -3.03M | -2.32M | -2.81M | -4.80M |
| Investing Cash Flow | -176.70K | -176.70K | -682.43K | -132.93K | -35.20K | -118.20K |
| Financing Cash Flow | 6.12M | 6.12M | 3.87M | 2.82M | 351.00K | -52.70K |
Terragen Holdings Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Positive. The current price of 0.01 is above the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 79.15 is Negative, neither overbought nor oversold. The STOCH value of 175.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:TGH.
Terragen Holdings Ltd Peers Comparison
Overall Rating
AU:NUF52Neutral
AU:CP843Neutral
AU:AMN40Underperform
AU:TGH40Underperform
AU:RLF38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 52Neutral | AUD 1.18B | -3.88 | -13.83% | ― | -6.75% | 46.98% | |
| 43Neutral | AUD 51.29M | -17.12 | -22.21% | ― | -30.52% | -19.67% | |
| 40Underperform | AUD 14.04M | -7.50 | -6.36% | ― | ― | 96.72% | |
| 40Underperform | AUD 12.35M | -2.42 | -52.55% | ― | -11.34% | 30.34% | |
| 38Underperform | AUD 16.65M | -1.80 | -88.51% | ― | -0.48% | -195.74% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:TGH | Terragen Holdings Ltd | 0.01 | -0.01 | -37.50% | |
| AU:CP8 | Canadian Phosphate Limited | 0.13 | 0.09 | 195.45% | |
| AU:NUF | Nufarm Limited | 3.06 | 0.59 | 23.89% | |
| AU:AMN | Agrimin Limited | 0.04 | -0.04 | -51.35% | |
| AU:RLF | RLF AgTech Ltd | 0.03 | -0.04 | -60.94% | |
| AU:KM1 | Kali Metals Limited | 0.08 | -0.11 | -58.95% |
Terragen Holdings Ltd Corporate Events
Terragen Advances Key Feedlot Trials and Secures Brazilian Export Approval
Terragen reported a solid operational quarter to 30 September 2026, advancing major feedlot trials with Mort & Co and Agriculture and Agri-Food Canada, and progressing a conditional supply agreement with Ravensworth Feedlot that is on track for first...
Terragen director Richard Norton steps down, retains indirect equity exposure
Terragen Holdings Ltd has announced that director Richard Norton ceased to be a director of the company on 28 October 2026, with a final disclosure of his relevant interests lodged under ASX listing rule 3.19A.3. While Norton held no securities in hi...
Terragen Names Interim CEO as CFO Withdraws Resignation
Terragen Holdings Limited has appointed Chief Operating Officer Dr Joss West as interim Chief Executive Officer, effective immediately, following earlier executive changes disclosed to the market. The company has also confirmed that Chief Financial O...
Terragen CEO Richard Norton Resigns as Board Launches Search for Successor
Terragen Holdings Ltd announced that Chief Executive Officer Richard Norton has resigned, effective 28 October 2026, marking a significant leadership change for the agritech company. The board publicly thanked Norton for his contributions during his...
Terragen Sets Virtual-Only AGM for 27 November 2026
Terragen Holdings Ltd has scheduled its 2026 Annual General Meeting for 9:00 a.m. Melbourne time on Friday, 27 November 2026. The meeting will be conducted entirely online as a virtual-only event, with shareholders able to participate via the specifi...
Terragen discloses final director interest as Michele Allan departs board
Terragen Holdings Ltd has announced that Dr Michele Allan AO has ceased serving as a director of the company as of 16 October 2026, and lodged a final director’s interest notice with the ASX. The filing details that Dr Allan holds a total of 3.5 mill...
Terragen appoints fractional CFO after finance chief resigns
Terragen Holdings Limited has announced the resignation of Chief Financial Officer and Joint Company Secretary Daniel Pearce, effective immediately, and moved to an outsourced model for financial leadership. The company has engaged Traverse Accountan...
Terragen Sets Date and Nomination Process for 2026 AGM
Terragen Holdings Limited has scheduled its 2026 Annual General Meeting for Friday, 27 November 2026, with the election of directors to be included as an item of business. The company has outlined the timetable and process for director nominations an...
Terragen Details Compliance With ASX Corporate Governance Standards
Terragen Holdings Limited has detailed its corporate governance practices for the 2025–26 financial year, confirming alignment with the ASX Corporate Governance Council’s latest principles and recommendations. The board emphasises clear oversight of...
Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes
Terragen Holdings Limited, an agricultural biotechnology company, develops and markets biological products aimed at improving livestock and crop performance for farmers and agribusiness clients. Operating in a specialised agri-tech niche, the company...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 27, 2026
